Karnataka to appeal HC order on Jan Aushadi Kendras closure
Karnataka Health Minister Dinesh Gundu Rao announces state will appeal HC order quashing closure of Jan Aushadi Kendras in govt hospitals. Read the full story.
Karnataka Health Minister Dinesh Gundu Rao announces state will appeal HC order quashing closure of Jan Aushadi Kendras in govt hospitals. Read the full story.
Delhi's Drugs Control department sealed a shop & collected 204 samples from 27 wholesale dealers in a major drive against illegal drug trade. Health Minister vows zero tolerance for spurious medicines.
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
Essential medicines meant for a govt hospital in Madhepura were found dumped in garbage, sparking public outrage. Officials promise probe and action. #Madhepura #HealthScandal
Maharashtra government allocates ₹9.6 crore for handheld drug analyzers to combat fake medicines in eight divisions. Read how this move strengthens public healthcare safety.
APSRTC union urges govt to restore free medicines for retired employees, citing hardship after merger. They demand a return to the pre-merger medical scheme benefits. Read more.
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
Eight students in Chhattisgarh's Kanker district fell ill after inhaling toxic fumes from burnt expired medicines at a nearby health centre. Read about the incident and the demand for an inquiry.
The UK's NHS will pay 25% more for innovative drugs in a new US trade deal, costing £3bn over three years. In return, UK pharma exports to the US avoid hefty tariffs. Read the full analysis.
Jharkhand High Court directs state authorities to stop illegal sale of intoxicating cough syrups and psychiatric medicines without prescriptions. Raids ordered to combat substance abuse among students.
Expert warns against self-medication for children. Common drugs like cough syrup & aspirin can be dangerous. Always consult a pediatrician first.
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
A software engineer in Bengaluru was cheated of ₹48 lakh by an Ayurvedic shop owner selling harmful sexual health medicines that caused kidney damage. Read the shocking details and police action.
Novo Nordisk reduces Wegovy's price by 37% in India as it faces patent loss and competition from Eli Lilly's Mounjaro and upcoming generic versions. Discover the new costs.
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
Himachal Pradesh drug control authorities raid Baddi pharmaceutical facility after Rajasthan complaints reveal distribution of sub-standard medicines across seven districts, raising serious public health concerns.
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
In a major healthcare move, Punjab government prohibits sale of 112 substandard drugs following quality control tests. Find out which medications are affected and what this means for public health safety.
Leading neurologist reveals how everyday medicines for depression, pain, and blood pressure can cause life-threatening hyponatremia. Learn the warning signs and protect yourself.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Neurologist warns about unexpected side effects of common blood pressure and diabetes medications in older adults. Learn the signs and when to consult your doctor.
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
Massive drug crackdown in Uttar Pradesh as officials confiscate illegal cough syrup worth ₹3 crore from a Sonbhadra warehouse. Investigation reveals sophisticated smuggling operation.
India mandates safety QR codes on all essential medicines in public healthcare, transforming drug safety and combating counterfeit drugs with digital innovation.
A Hyderabad pediatrician's shocking discovery of fake ORS packets sparks nationwide concern. Learn how counterfeit electrolytes threaten children's lives and what authorities are doing about it.
In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.